Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
8.070 USD   +3.46%
12/01Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit
PR
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PROTAGONIST THERAPEUTICS, INC.
12/01Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology S..
PR
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintain..
MT
11/08Protagonist Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/08Protagonist Therapeutics : Q3 Earnings Snapshot
AQ
11/02Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medic..
PR
11/02Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medic..
CI
09/20Protagonist Therapeutics Reports Granting of Inducement Award
PR
08/25JMP Securities Reinstates Protagonist Therapeutics at Market Outperform With $21 Price ..
MT
08/04Protagonist Therapeutics : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/04Protagonist Therapeutics : Q2 Earnings Snapshot
AQ
08/04Protagonist Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six ..
CI
08/04Protagonist Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Corp..
PU
07/19Protagonist Therapeutics Reports Granting of Inducement Award
PR
06/24Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
CI
More most relevant news
All news about PROTAGONIST THERAPEUTICS, INC.
12/01Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology S..
PR
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintain..
MT
11/08PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
11/08Protagonist Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/08Protagonist Therapeutics : Q3 Earnings Snapshot
AQ
11/02Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medic..
PR
11/02Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medic..
CI
09/20Protagonist Therapeutics Reports Granting of Inducement Award
PR
08/25JMP Securities Reinstates Protagonist Therapeutics at Market Outperform With $21 Price ..
MT
More news
News in other languages on PROTAGONIST THERAPEUTICS, INC.
11/08Protagonist Therapeutics, Inc. annonce ses résultats pour le troisième trimestre et les..
11/02Protagonist annonce la nomination d'Arturo Molina, M.D., M.S., F.A.C.P. au poste de dir..
08/04Protagonist Therapeutics, Inc. annonce ses résultats pour le deuxième trimestre et le s..
05/26Protagonist Therapeutics, Inc. présentera les résultats cliniques actualisés de la phas..
05/04Protagonist Therapeutics, Inc. publie ses résultats pour le premier trimestre clos le 3..
04/26Les actions de Protagonist Therapeutics chutent après la publication des résultats d'un..
04/25Protagonist Therapeutics annonce les premières données de l'étude IDEAL de phase 2 sur ..
04/14Mise à jour sectorielle : Les actions du secteur de la santé s'e..
04/14L'action Protagonist chute jeudi alors que la FDA prévoit d'annuler la désignation de d..
04/14Mise à jour sectorielle : Les actions du secteur de la santé en ..
More news
Analyst Recommendations on PROTAGONIST THERAPEUTICS, INC.
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintain..
MT
08/25JMP Securities Reinstates Protagonist Therapeutics at Market Outperform With $21 Price ..
MT
05/18Piper Sandler Adjusts Price Target on Protagonist Therapeutics to $35 From $60, Reitera..
MT
05/05SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $30 from $50, Keeps Outpe..
MT
02/11BTIG Initiates Protagonist Therapeutics at Buy With $55 Price Target
MT
More recommendations
Press releases
12/01Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology S..
PR
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/08PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
11/08Protagonist Therapeutics : Q3 Earnings Snapshot
AQ
11/02Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medic..
PR
More press releases
Upcoming event on PROTAGONIST THERAPEUTICS, INC.